English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Several European law documents (including the Charter of Fundamental Rights of the European Union) lay down a general prohibition on making the human body and its parts, as such, a source of financial gain. Scholars have identified three reasons for this prohibition: human dignity, equality, and solidarity. This paper aims at exploring to what extent non-gratuitous contracts on human biological samples can be validly concluded for purposes of research and commercial applications of the research results. In particular, the present paper will firstly, analyse the role of the three aforementioned reasons – dignity, equality, and solidarity – in the assessment of the validity of non-gratuitous contracts on human biological samples for the purposes of research and possible commercial uses thereof. Secondly, this paper will outline some possible advantages of excluding this kind of contracts from the scope of application of the prohibition of financial gain.

Contracts on Human Biological Samples: the European Prohibition of Financial Gain from the Human Body and its Parts